Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CVRXNASDAQ:LNSRNYSE:RBOTNASDAQ:RPID On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCVRXCVRx$6.58+1.9%$6.44$4.30▼$18.55$171.56M1.23317,512 shs66,165 shsLNSRLENSAR$13.19+0.8%$13.37$3.50▼$17.31$155.50M0.591,881 shs92,442 shsRBOTVicarious Surgical$7.61+3.4%$7.84$4.27▼$19.00$45.14M1.429,985 shs5,771 shsRPIDRapid Micro Biosystems$3.70+4.5%$3.17$0.61▼$4.04$162.18M1.32196,145 shs39,769 shs10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCVRXCVRx+1.86%+12.10%-2.66%-43.86%-44.00%LNSRLENSAR+0.76%+5.09%-2.59%-4.77%+189.23%RBOTVicarious Surgical+3.12%-1.35%+6.00%+36.14%+9.81%RPIDRapid Micro Biosystems+4.52%+6.32%-0.80%+68.95%+513.60%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCVRXCVRx2.7844 of 5 stars3.41.00.00.02.14.20.6LNSRLENSAR1.4377 of 5 stars2.03.00.00.02.52.50.0RBOTVicarious Surgical2.4378 of 5 stars2.04.00.00.02.42.51.3RPIDRapid Micro Biosystems1.5158 of 5 stars2.04.00.00.00.62.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCVRXCVRx 2.71Moderate Buy$14.50120.36% UpsideLNSRLENSAR 2.00Hold$15.0013.73% UpsideRBOTVicarious Surgical 2.00Hold$9.2521.55% UpsideRPIDRapid Micro Biosystems 4.00Strong Buy$8.00116.22% UpsideCurrent Analyst Ratings BreakdownLatest RBOT, RPID, CVRX, and LNSR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/9/2025CVRXCVRxPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$20.00 ➝ $12.005/9/2025CVRXCVRxJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Underweight$15.00 ➝ $7.004/8/2025CVRXCVRxLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$19.00 ➝ $14.004/8/2025CVRXCVRxCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$23.00 ➝ $18.00(Data available from 7/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCVRXCVRx$52.87M3.24N/AN/A$2.93 per share2.25LNSRLENSAR$53.49M2.91N/AN/A$0.42 per share31.40RBOTVicarious SurgicalN/AN/AN/AN/A$7.89 per shareN/ARPIDRapid Micro Biosystems$29.65M5.47N/AN/A$1.75 per share2.11Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCVRXCVRx-$59.97M-$2.18N/AN/AN/A-97.49%-79.04%-42.37%8/4/2025 (Estimated)LNSRLENSAR-$31.40M-$4.85N/A∞N/A-99.17%-737.30%-81.69%8/6/2025 (Estimated)RBOTVicarious Surgical-$63.22M-$10.45N/AN/AN/AN/A-120.53%-85.51%8/11/2025 (Estimated)RPIDRapid Micro Biosystems-$46.89M-$1.03N/AN/AN/A-151.22%-56.07%-44.11%8/1/2025 (Estimated)Latest RBOT, RPID, CVRX, and LNSR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/1/2025Q2 2025RPIDRapid Micro Biosystems-$0.26N/AN/AN/A$7.10 millionN/A5/12/2025Q1 2025RBOTVicarious Surgical-$2.61-$2.58+$0.03-$2.60N/AN/A5/9/2025Q1 2025RPIDRapid Micro Biosystems-$0.27-$0.26+$0.01-$0.26$6.63 million$7.21 million5/8/2025Q1 2025CVRXCVRx-$0.56-$0.53+$0.03-$0.53$14.68 million$12.35 million5/8/2025Q1 2025LNSRLENSAR-$0.1550-$2.32-$2.1650-$2.32$13.40 million$11.53 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCVRXCVRxN/AN/AN/AN/AN/ALNSRLENSARN/AN/AN/AN/AN/ARBOTVicarious SurgicalN/AN/AN/AN/AN/ARPIDRapid Micro BiosystemsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCVRXCVRx0.7114.8213.45LNSRLENSARN/A1.811.25RBOTVicarious SurgicalN/A5.055.05RPIDRapid Micro BiosystemsN/A4.613.23Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCVRXCVRx75.27%LNSRLENSAR40.15%RBOTVicarious Surgical47.27%RPIDRapid Micro Biosystems52.60%Insider OwnershipCompanyInsider OwnershipCVRXCVRx13.90%LNSRLENSAR38.52%RBOTVicarious Surgical11.99%RPIDRapid Micro Biosystems29.96%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCVRXCVRx16026.07 million22.45 millionOptionableLNSRLENSAR11011.79 million7.25 millionOptionableRBOTVicarious Surgical35.93 million5.22 millionNo DataRPIDRapid Micro Biosystems20043.83 million30.70 millionNot OptionableRBOT, RPID, CVRX, and LNSR HeadlinesRecent News About These CompaniesFavourable Signals For Rapid Micro Biosystems: Numerous Insiders Acquired StockJuly 3 at 4:08 PM | finance.yahoo.comRapid Micro Biosystems, Inc. (NASDAQ:RPID) Sees Large Decrease in Short InterestJune 18, 2025 | marketbeat.comRapid Micro Biosystems Grants Equity Awards to New Employee as Inducement for EmploymentJune 13, 2025 | quiverquant.comQRapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 13, 2025 | globenewswire.comCitadel Advisors LLC Buys Shares of 72,024 Rapid Micro Biosystems, Inc. (NASDAQ:RPID)June 11, 2025 | marketbeat.comRapid Micro Biosystems Appoints Dr. Dafni Bika to Board of DirectorsMay 29, 2025 | nasdaq.comRapid Micro Biosystems Announces Appointment of Dr. Dafni Bika to Board of DirectorsMay 27, 2025 | globenewswire.comEarnings call transcript: Rapid Micro Biosystems Q1 2025 shows revenue growthMay 10, 2025 | investing.comRapid Micro Biosystems, Inc. (NASDAQ:RPID) Q1 2025 Earnings Call TranscriptMay 10, 2025 | msn.comRapid Micro Biosystems, Inc.: Rapid Micro Biosystems Reports First Quarter 2025 Financial ResultsMay 10, 2025 | finanznachrichten.deWhy Rapid Micro Biosystems, Inc.’s (RPID) Stock Is Up 26.12%May 9, 2025 | aaii.comARapid Micro Biosystems, Inc. (RPID) Q1 2025 Earnings Call TranscriptMay 9, 2025 | seekingalpha.comRapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue EstimatesMay 9, 2025 | zacks.comRapid Micro Biosystems Reports First Quarter 2025 Financial ResultsMay 9, 2025 | globenewswire.comRapid Micro Biosystems to Announce First Quarter 2025 Financial Results on May 9, 2025April 24, 2025 | globenewswire.comRapid Micro Biosystems, Inc.'s (NASDAQ:RPID) largest shareholders are retail investors with 36% ownership, private equity firms own 33%April 21, 2025 | finance.yahoo.comRapid Micro Biosystems, Inc. (RPID): A Bull Case TheoryApril 4, 2025 | insidermonkey.comIs Rapid Micro Biosystems Inc. (RPID) the Popular Penny Stock on Robinhood to Watch?March 27, 2025 | msn.comIs Rapid Micro Biosystems (RPID) One of the Penny Stocks With Huge Upside Potential According to Analysts?March 23, 2025 | insidermonkey.comRapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)March 12, 2025 | globenewswire.comRapid Micro Biosystems, Inc. (NASDAQ:RPID) Q4 2024 Earnings Call TranscriptMarch 3, 2025 | insidermonkey.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeRBOT, RPID, CVRX, and LNSR Company DescriptionsCVRx NASDAQ:CVRX$6.58 +0.12 (+1.86%) Closing price 07/3/2025 03:31 PM EasternExtended Trading$6.50 -0.08 (-1.22%) As of 07/3/2025 04:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.LENSAR NASDAQ:LNSR$13.19 +0.10 (+0.76%) As of 07/3/2025 01:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.Vicarious Surgical NYSE:RBOT$7.61 +0.25 (+3.40%) As of 07/3/2025 03:30 PM EasternVicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.Rapid Micro Biosystems NASDAQ:RPID$3.70 +0.16 (+4.52%) Closing price 07/3/2025 03:02 PM EasternExtended Trading$3.70 0.00 (0.00%) As of 07/3/2025 04:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; RMBNucleus Central Manager portal streamlines coordination of multiple instruments; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. The company was incorporated in 2006 and is headquartered in Lowell, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Rocket Lab: Latest Catalysts Bolster the Bull Case Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
